|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing that utilizes cancer biomarkers in the blood to screen for multiple cancers simultaneously (ACS, 2024). Currently, numerous clinical trials are investiga... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States (ACS, 2024; Pinsky & Berg, 2012; USPSTF, 2024). Multicancer early detection (MCED) is a novel form of blood-based ca... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Musculoskeletal Ultrasound: Advanced Interventions & Regenerative Medicine - Live Course
The Musculoskeletal Ultrasound: Advanced Interventions & Regenerative Medicine Training Course is taught by leading experts in the field of MSK ultrasound. This course takes your musculoskeletal ultrasound skills to the next level with a focus on advanced diagnostic and interventional skills including spine, peripheral nerve, tendinopathy and ultrasound-guided tenotomy. Regenerative medicine applications including prolotherapy, platelet-rich plasma (PRP), bone-marrow aspirate concentrate (... |
|
|
Advances In the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician - Part 3
Target Audience
This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers, and Endocrine Nurses.
Program Overview
During this program, experts will present overviews of the importance of early screening and staging for type 1 diabetes (T1D), strategies and practical pearls for screening and follow-up, how to intervene early with disease-modifying therapies to delay progression to clinical T1D, as well as ongoing ... |
|
|
Recognizing and Confirming Potential ATTR in Your Patients
Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.
Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part ... |
|
|
Navigating the Evolving Standards of Newly Diagnosed Multiple Myeloma Treatment: Exploring the Evidence on New Combination Strategies
ACTIVITY DESCRIPTION
The goal of treatment for newly diagnosed multiple myeloma (NDMM) patients is achieving the deepest possible remission, which typically involves aiming for minimal residual disease negativity. Frontline therapy for NDMM is evolving to include novel induction regimens with anti-CD38 antibodies, which have been shown to yield improved depth of response after induction. These new frontline treatments vary in induction regimen composition and use of transplant, consolidation,... |
|
|
Improving the Diagnosis and Management of Pulmonary Progressive Fibrosis (PPF): A Focus on Systemic Sclerosis Interstitial Lung Disease (SSc-ILD) and Idiopathic Pulmonary Fibrosis (IPF)
Target Audience
This activity is designed to meet the educational needs of rheumatologists, pulmonologists, and advanced practice providers.
Program Overview
This activity features an interactive case-based format where you can review questions to determine best practices in diagnosing and managing PPF, SSc-ILD, and IPF. This session offers real-life examples to help differentiate diseases within the Pulmonary Progressive Fibrosis (PPF) group, such as Idiopathic Pulmonary Fibrosis (IPF) a... |
|
|
Clinical Competence in Cardiac CT Compendium
Supplemented with all new presentation content and worth up to 60.5 AMA PRA Category I Credits™, the Clinical Competence in Cardiac CT Compendium will help meet credentialing and/or maintenance requirements for Cardiac CT. Each case features a simulated workstation, with hundreds of datasets of fully navigable imagines, supplement diagnostic materials and detailed description of findings by expert faculty. The cases present a wide variety of cardiovascular pathology, including the assessme... |
|
|
Bunion-Like Toes and Tumor Like Swellings " Recognize FOP and Improve Patient Outcomes in the Era of Disease Specific Therapy
Target Audience
This activity is designed to meet the educational needs of healthcare providers in pediatrics, primary care, oncology, surgery, radiology, acute care, emergency medicine, rheumatology, and infectious disease.
Program Overview
Bunion-like toes present at birth and tumor-like swellings in a young child are diagnostic signs of fibrodysplasia ossificans progressive (FOP), a disease with recent advances made in therapy. Upon completion of the course, learners should be able to ... |
|
|
Podcast: Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
With the complex and rapidly evolving treatment landscape of multiple myeloma, it is vital that clinicians not only understand factors for informing selection of current and emerging combination and sequential therapeutic strategies, but also employ interdisciplinary strategies for reducing disparities in relapsed/refractory multiple myeloma care. The development of novel therapeutic options has significantly improved treatment outcomes for patients with relapsed/refractor... |
|
|
Defining the therapeutic algorithm in patients with HR positive breast cancer - United States
Target Audience
The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer
Learning Objectives
Upon completion of this activity, participants should be better able to:
Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall
Apply the most recent evid... |
|
|
Antibody Drug Conjugates (ADC) - United States
Target Audience
The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer.
Learning Objectives
Upon completion of this activity, participants should be better able to:
Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall
Apply the most recent evi... |
|
|
Bridging the Health Gaps in Hereditary Angioedema: Demystifying Disparities, Enhancing Quality of Life, and Implementing Effective Prophylactic Solutions
Hereditary angioedema (HAE) is a rare, life-threatening disorder characterized by recurrent, unpredictable episodes of bradykinin-induced swelling. In this presentation, Dr. Marc Reidl, Clinical Director of the US Hereditary Angioedema Association (HAEA) Angioedema Center, reviews multiple underrecognized factors that contribute to health disparities among patients with HAE, including delays in diagnosis and multifaceted differences among racial and ethnic groups, socioeconomic status levels, ... |
|
|
Ace the Case: A 15-Year-Old Girl With a Remote History of Rash While Taking Amoxicillin
This educational activity will utilize a case study to discuss a 15-year-old girl with a remote history of a rash while taking amoxicillin. |
|
|
Ace the Case: A 77-Year-Old Man With Chronic Heartburn and Persistent Abdominal Pain
This educational activity will utilize a case study to discuss a 77-year-old man who presents with a history of chronic heartburn and 3 months of persistent abdominal pain. |
|
|
Ace the Case: A 38-Year-Old Man With Resistant Hypertension
This educational activity will utilize a case study to discuss a 38-year-old man with resistant hypertension. |
|
|
Ace the Case: A 47-Year-Old Woman With Lethargy, Confusion, and Muscle Weakness
This educational activity will utilize a case study to discuss a 47-year-old woman with lethargy, confusion, and muscle weakness. |
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
|
Hypertrophic Cardiomyopathy: Unmasking Disparities and Forging a Path to Equitable Care
This comprehensive continuing education (CE) monograph delves into the complexities of HCM, an autosomal dominant genetic disorder marked by increased left ventricular hypertrophy. This condition can lead to significant health complications, such as heart failure, arrhythmias, stroke, and sudden cardiac death. Despite the impact of HCM on patient health and well-being, a gap persists in the understanding of the racial/ethnic and gender-based disparities among healthcare professionals. This gap... |
|
|
Best of ACTHIV®: HIV 101 " Pathogenesis
Description:
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2023 conference for the frontline HIV care team, this activity will describe HIV infection and viral dynamics, define how viral dynamics impact management of antiretroviral therapy, and describe current progress in area of HIV cure/remission
Learning Objectives
After participating in the activity, learners should be better able to:
Describe HIV infection and viral d... |
|
|
Best of ACTHIV® 2024: HIV the Basics"Primary Care in HIV
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on best practices for a new patient intake for someone diagnosed with HIV, including asking relevant medical, social and historical information, and ensuring appropriate lab tests, diagnostic imaging and vaccinations based on the history taken.
Learning Objectives
Complete a new patient intake for someone diagno... |
|
|
Best of ACTHIV® 2024: Beyond Viral Suppression: How Addressing Mental Health Directly Reduces Morbidity and Mortality in People with HIV
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on identifying causes of death that are direct outcomes of poor mental health among PWH, and provide guidance for the care team to better enable them to address mental health problems as a component of all HIV-related prevention, care and treatment approaches.
Learning Objectives
Identify three ca... |
|
|
Best of ACTHIV® 2024: Balancing Management of Multimorbidity and Polypharmacy in Aging PWH
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on how polypharmacy applies to people with HIV, complications of polypharmacy, and how care teams can work together to identify patients who might benefit from deprescribing.
Learning Objectives
Describe polypharmacy and how it applies to People with HIV (PWH)
List complications of polypharma... |
|
|
Best of ACTHIV® 2024: Aging with HIV and the Challenge of Multimorbidity
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on multimorbidity and its implications in the care of older people with HIV as well as approaches to screening for and managing multimorbidity and aging-related syndromes for the care team.
Learning Objectives
Recognize the changing demographics of HIV and comorbidity burden
Explain multimorb... |
|
|
Best of ACTHIV® 2024: Sexually Transmitted Infections: Epidemiology and Missed Opportunities
Description
Selected by attendees and the program planning committee as one of the best sessions of the ACTHIV® 2024 conference for the frontline HIV care team, this activity will focus on current trends of common nationally notifiable STIs, potential challenges to diagnosing and treating chlamydia, gonorrhea, and syphilis, and how teams can apply knowledge of screening and treatment of syphilis in pregnant persons to prevent congenital syphilis.
Learning Objectives
Describe the ... |
|
|
Treating SCLC in the Relapsed/Refractory Setting: Giving Patients a Voice About Second-Line Therapy
SCLC is aggressive in nature with a high recurrence rate following initial treatment and a propensity to become resistant to conventional therapies. Early detection is critical, but many patients are diagnosed at an advanced stage where prognosis is poor. Progress in the second-line setting offers new hope for improving patient outcomes, but the rapid pace at which these advances are occurring present challenges for effectively integrating novel therapies into patient care. In fact, research s... |
|
|
Chronic Rhinosinusitis with Nasal Polyps Navigating New Pathways to Better Patient Outcomes
Chronic inflammatory diseases of the upper and lower airways, especially CRSwNP and asthma, have been tied to significant risks and burdens for affected patients and frequently require close coordinated multidisciplinary care. Targeted agents designed to interrupt inflammatory cytokine signaling have been examined in clinical trials and evidence suggests these options can provide a range of benefits in patients with CRSwNP and related comorbidities. During this interactive activity, expert fac... |
|
|
Patient Point of View: PDE4 Inhibitors for the Treatment of Adult Plaque Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory skin disorder that significantly impacts affected individuals’ quality of life. The most common subtype is plaque psoriasis, characterized by erythematous to violaceous plaques covered with scales. Due to the substantial symptom burden of plaque psoriasis and challenges surrounding medication tolerability and adherence, innovative treatment options are needed. Phosphodiesterase-4 (PDE4) inhibitors, which play a key role in the inflammatory... |
|
|
Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies
In this Hematology Dialogues, Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disorders: Addressing Unmet Needs with Emerging Therapies, participants will learn about the epidemiology and burden of Epstein-Barr Virus-positive (EBV+) and post-transplant lymphoproliferative disorders (PTLD), differentiate between current and emerging prognostic scoring systems for EBV+ and PTLD to inform treatment decisions, and evaluate the latest clinical evidence of emerging treatment options ... |
|
|
Overcoming the Hurdles: Advances in the Management of Hemophilia
In this fast-moving, 1-hour accredited activity, Craig Kessler, MD, and Guy Young, MD, share their thoughts and experience with clotting factor concentrates, recombinant factor, factor VIII mimetics, rebalancing agents, and gene therapies. The safety and efficacy of late-phase investigational products are also discussed as these agents have the potential to address unmet needs and further transform patient care. |
|
|
Cushing’s Syndrome Treatment Research Highlights: ENDO 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in endorcrinology, radiology, neurosurgery, and general practice. Other members of the care team may also participate.
Program Overview
This 30-minute CME program highlights the latest clinical research about Cushing’s syndrome and Cushing’ disease.
Learning Objectives
After participating in the activity, learners should be better able to:
Describe the latest research being ... |
|
|
Introduction to Emergency Medicine Ultrasound - Live Course
The Introduction to Emergency Medicine Ultrasound Live Training Course provides participants a strong foundation to perform the core emergency medicine ultrasound applications as outlined in the most recent ACEP ultrasound practice guidelines.
This course is taught by leading emergency medicine ultrasound experts and incorporates comprehensive lectures, interactive case presentations, and extensive hands-on scanning sessions. All hands-on scanning sessions feature a 3:1 participant to exper... |
|
|
Introduction to Critical Care Ultrasound - Live Course
The Introduction to Critical Care Ultrasound Live Training Course provides participants a strong foundation to perform the core critical care ultrasound applications as outlined in the most ACEP ultrasound practice guidelines.
This course is taught by leading critical care and emergency medicine ultrasound experts and incorporates comprehensive lectures, interactive case presentations, and extensive hands-on scanning sessions. All hands-on scanning sessions feature a 3:1 participant to expe... |
|
|
Can You Diagnose This Patient With Impaired Balance and Paresthesia?
When your patient presents with symptoms such as impaired balance and paresthesia, what might you first suspect and can you reach the right diagnosis? Put your diagnostic skills to the test! In just 15 minutes, navigate through real-world cases and upon completion, hear faculty insights on the implications of your decisions along with rationales for appropriate next steps to aid in making a final diagnosis, as well as evidence-based treatment strategies. Apply the latest scientific evidence in... |
|
|
Neuropsychiatric Complications of Parkinson’s Disease Psychosis
Target Audience
This activity is designed to meet the educational needs of Neurologists, neurology NPs, neurology PAs.
Program Overview
Join us for a dynamic one-hour CME activity on Parkinson’s Disease Psychosis (PDP) with top experts Mark F. Lew, MD, and Jennifer Hui, MD. Unlock the latest best practices for diagnosing PDP and implementing cutting-edge therapies. The session kicks off with a deep dive into Parkinson’s Disease, covering its prevalence, motor and nonmotor symptoms, an... |
|
|
Opportunities with Novel Therapies to Treat the Entire Spectrum of Schizophrenia Symptoms
Available antipsychotic therapies for schizophrenia are effective in treating positive symptoms of schizophrenia yet significant unmet needs remain, including therapies that (1) are more effective in reducing negative and cognitive symptoms of schizophrenia; 2) have improved tolerability and adherence rates; and (3) that are effective in treating refractory schizophrenia. Fortunately, the schizophrenia treatment landscape is poised to change dramatically, offering new opportunities for patient... |
|
|
Cushing’s Syndrome Treatment Research Highlights
This 30-minute CME program highlights the latest clinical research about Cushing’s syndrome and Cushing’ disease.
Cushing’s syndrome is rare endocrine disorder characterized by chronic hypercortisolism. It is often due to a pituitary adenoma producing excessive ACTH leading to hypercortisolism. Symptoms can range from mild to extensive.
This CME program, hosted by Maria Fleseriu, MD, FACE, Professor of Medicine and Neurological Surgery, Director of the Pituitary Center at Oregon He... |
|
|
HER3 in NSCLC " Navigating New Frontiers in Targeted Therapy
In patients with non-small cell lung cancer (NSCLC), human epidermal growth factor receptor 3 (HER3) is associated with both advanced disease and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)"directed therapies. Although there are therapeutic options targeting EGFR (HER1) and HER2, the potential of HER3 as an anti-cancer target has been largely overlooked. Overexpression of HER3 in most patients with NSCLC positions it as an appealing therapeutic targ... |
|
|
Case Studies in ART and Retention in Care
Webinar Highlights:
It is estimated that approximately 54% of patients with HIV in the United States were retained in care in 2022. By remaining engaged in care, patients are more likely to be adherent to antiretroviral therapy resulting in viral suppression, improved patient outcomes and prevent the spread of HIV.
Through a series of cases, our interprofessional faculty educators will discuss potential barriers to retention in care commonly encountered by the healthcare team and provide ... |
|
|
Advanced Emergency Medicine Ultrasound - Live Course
The Advanced Emergency Medicine Ultrasound Live Training Course is designed to build on the knowledge base of experienced emergency medicine and critical care ultrasound professionals using the most up-to-date ACEP advanced ultrasound topics.
This course is taught by leading emergency medicine & critical care ultrasound experts and incorporates comprehensive lectures, interactive case presentations, and extensive hands-on skills training. All hands-on sessions feature a 3:1 participant ... |
|
|
Advanced Critical Care Ultrasound - Live Course
The Advanced Critical Care Ultrasound Live Training Course is designed to build on the knowledge base of experienced emergency medicine and critical care ultrasound professionals using the most up-to-date ACEP advanced ultrasound topics.
This course is taught by leading emergency medicine & critical care ultrasound experts and incorporates comprehensive lectures, interactive case presentations, and extensive hands-on scanning sessions. The hands-on scanning sessions feature a 3:1 parti... |
|
|
Advances in Recurrent/Metastatic Nasopharyngeal Carcinoma: Immunotherapy and Biomarkers
Target Audience
This activity was developed for medical oncologists, head and neck surgeons, radiation oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients diagnosed with metastatic nasopharyngeal carcinoma (NPC).
Program Overview
Greater understanding of the tumor microenvironment of nasopharyngeal carcinoma (NPC) has led to the introduction of immunotherapy into the NPC treatment landscape. Incorporating immunotherapy has change... |
|
|
Cracking the Code to Successful Stem Cell Mobilization in Multiple Myeloma
STATEMENT OF NEED
Multiple myeloma is the leading indication of autologous hematopoietic stem cell transplantation (ASCT) in hematologic malignancies, with high-dose therapy followed by ASCT representing a potentially curative treatment modality for eligible patients. Collecting peripheral blood stem cells (PBSCs) is an essential component of ASCT, and the collection of sufficient autologous PBSCs relies on the successful mobilization of hematopoietic stem cells from the bone marrow niche i... |
|
|
Introduction to OB/Gyn Ultrasound - Blended Course
The Introduction to OB/GYN Ultrasound Blended Course will give you a strong foundation to begin performing and/or interpreting comprehensive gynecological and 1st, 2nd, and 3rd trimester OB ultrasound applications.
Begin with the self-paced online course: Taught by leading OB/GYN ultrasound experts, the comprehensive online course covers transabdominal and endovaginal gynecological and 1st, 2nd, and 3rd trimester OB ultrasound applications, including fetal anomalies. The online course incor... |
|
|
Point-of-Care OB/Gyn Ultrasound - Blended Course
The Point-of-Care OB/GYN Ultrasound Blended Course, specifically designed for physicians and mid-level/advanced practice providers, will provide a strong foundation to utilize ultrasound to visualize maternal and fetal anatomy to enhance accurate and timely clinical decisions at the bedside.
Begin with the self-paced online course: Taught by leading OB/GYN ultrasound experts, the comprehensive online course covers point-of-care gynecological sonoanatomy & scan technique, sonographic app... |
|
|
Halting the Spiral in Worsening Heart Failure: A Virtual Patient Simulation.
Target Audience
The intended audience for this activity includes cardiologists and cardiology advanced practice providers involved in the management of patients with heart failure.
Program Overview
Despite advances in guideline-directed medical therapy, patients with heart failure with reduced ejection fraction (HFrEF) often experience worsening symptoms, leading to increased hospital admissions and a higher risk of adverse outcomes. Halting the Spiral in Worsening Heart Failure: A Virtua... |
|